Suppr超能文献

混合淋巴细胞培养产生的细胞群体对人自然杀伤细胞细胞毒性的抑制作用。

Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.

作者信息

D'Amore P J, Golub S H

出版信息

J Immunol. 1985 Jan;134(1):272-9.

PMID:3155463
Abstract

A suppressor cell generated in late MLC was capable of inhibiting the cytotoxic activity of fresh NK cells and MLC-generated NK-like cells. Maximum suppression was obtained by using the cells from a 12-day MLC and resulted in a 47% inhibition in fresh NK activity as measured by 51Cr release. The inhibition was also apparent in the single-cell cytotoxicity assay, where suppression was manifested at the level of target recognition. This was reflected in the number of target-binding conjugates (TBC), with a decreased number of TBC consistently found when day 12 MLC cells were added to fresh NK cells or MLC-generated NK-like cells. A soluble suppressive factor generated in MLC did not appear to be the mechanism underlying the suppression, because the addition of the supernatant from a 12-day MLC had no effect on the target binding or cytotoxic activity of fresh NK cells. An adherent cell population was not involved, as the removal of G-10 adherent cells from the day 12 MLC did not alter suppression of NK cytotoxicity. The phenotype of the regulatory cell in the day 12 MLC was Fcmu+ and HNK-1+ (Leu-7). These suppressor cells do not bear antigens detected by monoclonal antibodies to T cells (Leu-4), suppressor T cells (Leu-2a), HLA-DR, or the Fc gamma receptor on NK cells (B73.1). The manner in which the HNK-1+, Fcmu+ suppressor cells exerted their inhibitory effect was by binding directly to Fc gamma +, HNK-1+ fresh NK cells. In turn, the Fc gamma +, HNK-1+ NK cells were rendered incapable of binding to target cells. These results suggest that NK cells themselves can function as immunoregulators, controlling their own cytotoxic activity.

摘要

在混合淋巴细胞培养晚期产生的一种抑制细胞能够抑制新鲜自然杀伤细胞(NK细胞)以及混合淋巴细胞培养产生的类NK细胞的细胞毒性活性。使用来自12天混合淋巴细胞培养的细胞可获得最大抑制效果,通过51Cr释放法检测,新鲜NK细胞活性受到47%的抑制。在单细胞细胞毒性试验中,这种抑制也很明显,抑制作用在靶细胞识别水平体现出来。这反映在靶细胞结合共轭物(TBC)数量上,当将第12天混合淋巴细胞培养的细胞加入新鲜NK细胞或混合淋巴细胞培养产生的类NK细胞时,TBC数量持续减少。混合淋巴细胞培养中产生的可溶性抑制因子似乎不是抑制作用的潜在机制,因为加入第12天混合淋巴细胞培养的上清液对新鲜NK细胞的靶细胞结合或细胞毒性活性没有影响。抑制作用不涉及贴壁细胞群体,因为从第12天混合淋巴细胞培养中去除G - 10贴壁细胞不会改变对NK细胞毒性的抑制作用。第12天混合淋巴细胞培养中调节细胞的表型为Fcmu +和HNK - 1 +(Leu - 7)。这些抑制细胞不携带针对T细胞(Leu - 4)、抑制性T细胞(Leu - 2a)、HLA - DR或NK细胞上的Fcγ受体(B73.1)的单克隆抗体所检测到的抗原。HNK - 1 +、Fcmu +抑制细胞发挥抑制作用的方式是直接与Fcγ +、HNK - 1 +新鲜NK细胞结合。反过来,Fcγ +、HNK - 1 + NK细胞就无法与靶细胞结合。这些结果表明NK细胞自身可作为免疫调节因子,控制其自身的细胞毒性活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验